logo-loader
viewKanabo Research

Kanabo Research sets sights on London listing

Israeli-based Kanabo Research could become the first cannabis firm to list on the main market of the London Stock Exchange.
The company, which has developed a vaporiser for the inhalation of medical cannabis, is planning to list through a reverse takeover by cash shell Spinnaker Opportunities.
Spinnaker has signed a head of terms to buy Kanabo and the deal is waiting on UK approval.
Chief executive Avihu Tamir sat down with Proactive’s Andrew Scott to talk about the deal and Kanabo's move towards the commercialisation of its VapePod device.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Strategic Minerals boosts sales at Cobre and is assessing options to advance...

Strategic Minerals PLC's (LON:SML) John Peters tells Proactive London's Andrew Scott they've boosted sales at the Cobre magnetite project in the US, despite the disruption of the coronavirus pandemic. Quarterly sales were up 89% on quarter-end June 2019 and ahead 38% year-on-year. Peters says...

16 minutes ago

2 min read